Burn Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Advanced Dressings, Biologics, Traditional Burn Care Products and Others), By Depth Of Burn (Minor Burns, Partial Thickness Burns, and Full Thickness Burns), By Cause (Thermal Burns, Electrical Burns, Radiation Burns, Chemical Burns, and Friction Burns), By End Use (Hospitals, Outpatient Facilities, Home Care, and Research & Manufacturing), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.75 Billion
CAGR (2026-2031)	7.23%
Fastest Growing Segment	Hospitals
Largest Market	North America
Market Size (2031)	USD 4.18 Billion

Market Overview

The Global Burn Care Market will grow from USD 2.75 Billion in 2025 to USD 4.18 Billion by 2031 at a 7.23% CAGR. The global burn care market comprises a diverse array of medical solutions, including advanced dressings, biologics, and skin substitutes designed to manage partial to full-thickness thermal, chemical, and electrical injuries. Sector growth is primarily fueled by the rising global incidence of acute burn traumas and the increasing demand for effective treatments that minimize scarring and infection risks. Additionally, the expanding geriatric population serves as a critical driver as elderly patients typically require prolonged wound management and specialized care due to slower physiological healing processes.

However, market expansion is impeded by the significant expense associated with advanced biologics which limits accessibility in developing regions. Financial barriers are further compounded by complex reimbursement policies that often delay the widespread adoption of premium care solutions. Highlighting the financial magnitude of these injuries, according to the American Burn Association, in 2024, intensive care utilization for burn injuries resulted in over $660 million in annual costs within their data registry. This expenditure underscores the urgent demand for affordable therapeutic innovations that streamline recovery without imposing unsustainable economic burdens.

Key Market Drivers

The increasing global incidence of burn injuries acts as a primary catalyst for market growth, creating a sustained demand for immediate and long-term therapeutic interventions. Severe thermal and chemical traumas require complex medical management, ranging from initial fluid resuscitation to surgical debridement and rehabilitation. This high volume of acute cases directly compels healthcare systems to stockpile essential wound care resources and expand specialized treatment capacities to manage patient loads effectively. Highlighting the prevalence of these traumas, according to the American Burn Association, February 2024, in the '2024 Burn Injury Summary Report', flame and flash burns accounted for 46% of all admissions to U.S. burn centers, underscoring the critical need for robust trauma care protocols.

Simultaneously, rapid technological advancements in biologics and skin substitutes are reshaping the therapeutic landscape by offering improved clinical outcomes compared to traditional dressings. Innovations in cellular therapy and biodegradable scaffolds are accelerating wound closure and reducing hospital stays, driving their widespread adoption among clinicians. This shift toward advanced care solutions is evident in the financial performance of key industry players. For instance, according to Vericel Corporation, November 2024, in the 'Third Quarter 2024 Financial Results', the company's burn care net revenue surged 66% to $13.2 million, driven by strong demand for their biologic products. This momentum is further reflected in the broader sector; according to PolyNovo Limited, August 2024, in the 'Annual Report 2024', global sales of their NovoSorb BTM skin substitute increased by 54.5% over the previous year, signaling a robust market appetite for next-generation reconstructive solutions.

Download Free Sample Report

Key Market Challenges

The growth of the Global Burn Care Market is significantly restricted by the prohibitive costs associated with advanced biologics and the complexities surrounding reimbursement. Although these innovative therapies offer superior clinical outcomes, their high price points often exceed the budgets of healthcare facilities, particularly in developing regions. Consequently, medical providers are frequently forced to rely on traditional, less expensive wound care methods, thereby stifling the adoption rate of premium solutions. This financial friction is exacerbated by intricate reimbursement policies that create uncertainty and payment delays, deterring hospitals from investing in expensive inventories and limiting the addressable market for these technologies.

This economic pressure directly limits market penetration by narrowing the accessibility of specialized care. When the total financial burden of treatment becomes unsustainable, patient access to the advanced burn centers that utilize these products diminishes. Highlighting this disparity in access and cost, According to the American Burn Association, in 2024, transportation costs for rural patients were nearly double those of urban patients, with air transport specifically costing an additional $5,678. Such financial hurdles not only burden patients but also reduce the effective demand for advanced burn care technologies in underserved areas where specialized treatment is financially out of reach.

Key Market Trends

The Global Burn Care Market is witnessing a significant technological evolution with the development of smart bandages and bioelectronic dressings, marking a departure from passive wound management to active, real-time therapeutic intervention. These advanced systems integrate microelectronics and sensors directly into the dressing to monitor critical healing parameters such as pH levels, temperature, and infection biomarkers without requiring frequent, painful dressing changes. Beyond monitoring, these devices can deliver targeted electrical stimulation to accelerate tissue regeneration and disrupt bacterial biofilm formation. Validating the clinical efficacy of this technology, according to North Carolina State University, November 2024, in the article 'Battery-Powered Bandages Could Become a Simpler and More Affordable Treatment for Chronic Wounds', researchers demonstrated that their water-activated electric bandages healed chronic wounds 30% faster than conventional dressings in preclinical models.

Simultaneously, there is a distinct shift towards the utilization of fish skin grafts and natural biomaterials, driven by the demand for scaffolds that closely mimic human skin structure while offering unique biological benefits. Unlike traditional mammalian-derived skin substitutes, fish skin grafts are rich in Omega-3 fatty acids, which possess inherent anti-inflammatory properties and facilitate rapid cellular recruitment for vascularization. Furthermore, because there is no risk of viral transfer from fish to humans, these materials require less harsh processing, preserving their natural structure and efficacy. This growing adoption is reflected in recent market performance; according to Coloplast A/S, November 2024, in the 'Annual Report 2023/24', the company's Kerecis division, which specializes in fish-skin technology, delivered an underlying revenue growth of approximately 35%, significantly outpacing the broader wound care market.

Segmental Insights

Hospitals represent the fastest-growing segment in the Global Burn Care Market because they provide the intensive medical attention required for severe burn injuries. These facilities offer necessary infrastructure, such as dedicated burn units and surgical support, to manage complex cases effectively. The demand for hospital services is driven by the rising prevalence of burns that necessitate immediate inpatient care and long-term rehabilitation. Furthermore, organizations such as the World Health Organization highlight the need for specialized management of significant burn trauma, reinforcing the preference for hospitals over outpatient settings for critical treatment and recovery.

Regional Insights

North America maintains a dominant position in the global burn care market, driven by favorable reimbursement policies and substantial healthcare expenditure that ensure patient access to specialized treatments. The region benefits from the active presence of major industry manufacturers, which secures a steady supply of grafts and wound care products. Additionally, organizations such as the American Burn Association support standardized treatment protocols, while clear regulatory pathways provided by the U.S. Food and Drug Administration encourage the introduction of new therapeutic options. These elements collectively strengthen the regional market infrastructure.

Recent Developments

• In August 2024, Vericel Corporation announced that it had received approval from the U.S. Food and Drug Administration for a pediatric indication of its advanced burn care product, NexoBrid. This regulatory clearance authorized the use of the biological orphan product for eschar removal in pediatric patients with deep partial-thickness and full-thickness thermal burns. The President of Vericel Corporation highlighted that this approval provided a vital non-surgical option for treating severe burn injuries in children, a particularly vulnerable patient population. The decision was supported by data from a global Phase 3 clinical trial, which validated the safety and efficacy of the treatment in hospitalized pediatric burn patients.
• In July 2024, Mölnlycke Health Care announced a strategic collaboration and an investment of US $15 million in MediWound Ltd., strengthening its presence in the global burn care market. This partnership involved a private investment in public equity and a definitive share purchase agreement focused on advancing next-generation enzymatic therapeutics for non-surgical wound debridement. The Chief Executive Officer of Mölnlycke Health Care emphasized that the investment aligned with the company's strategy to bring radical innovations to wound care and provide alternatives to traditional surgical debridement. The agreement also granted Mölnlycke rights to participate in MediWound's research and development committee, facilitating closer cooperation on future burn treatment solutions.
• In May 2024, AVITA Medical obtained approval from the U.S. Food and Drug Administration for its RECELL GO skin restoration system, marking a significant technological advancement in the global burn care market. Following this regulatory milestone, the company initiated the commercial launch of the device, which automates the preparation of spray-on skin cells using a small sample of the patient's own skin. This system was designed to treat thermal burn wounds and full-thickness skin defects while streamlining clinical workflows. The Chief Executive Officer of AVITA Medical noted that the automated features would improve operational efficiency in burn centers and reduce the training burden on medical staff, ultimately enhancing patient recovery outcomes.
• In March 2024, Integra LifeSciences Holdings Corporation announced the commercial availability of MicroMatrix Flex in the United States, expanding its regenerative medicine portfolio within the global burn care market. This innovative dual-syringe system was engineered to enable the precise delivery of a flowable urinary bladder matrix paste, allowing surgeons to treat hard-to-reach areas in complex wound reconstructions. The Senior Vice President of the company’s Tissue Technologies Product Division stated that the product was developed to address significant treatment challenges and prepare even wound surfaces. The launch highlighted the company's dedication to improving standards of care for patients requiring management of irregular and deep wounds, including severe burns.

Key Market Players

• 3M Company
• Hollister Incorporated
• Cardinal Health, Inc.
• Integra LifeSciences Corporation
• Coloplast Corp.
• DeRoyal Industries, Inc.
• Smith & Nephew Plc
• Convatec Inc.
• Mölnlycke Health Care AB
• Johnson & Johnson

By Product	By Depth Of Burn	By Cause	By End Use	By Region
Advanced Dressings Biologics Traditional Burn Care Products and Others	Minor Burns Partial Thickness Burns and Full Thickness Burns	Thermal Burns Electrical Burns Radiation Burns Chemical Burns and Friction Burns	Hospitals Outpatient Facilities Home Care and Research & Manufacturing	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Burn Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Burn Care Market, By Product:

• Advanced Dressings
• Biologics
• Traditional Burn Care Products and Others

• Burn Care Market, By Depth Of Burn:

• Minor Burns
• Partial Thickness Burns
• and Full Thickness Burns

• Burn Care Market, By Cause:

• Thermal Burns
• Electrical Burns
• Radiation Burns
• Chemical Burns
• and Friction Burns

• Burn Care Market, By End Use:

• Hospitals
• Outpatient Facilities
• Home Care
• and Research & Manufacturing

• Burn Care Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE